EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Alteration of the Gut Microbiome in Inflammatory Bowel Disease

Akira Andoh, Atsushi Nishida

Digestion · 2023 · 104 (1) · 16-23

DOI: 10.1159/000525925 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestion, online erschienen am 28.07.2022. Verfasst von Akira Andoh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Shiga University of Medical Science, Otsu, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Crohn Disease. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Alteration of the gut microbial structure and function (dysbiosis) is associated with the pathogenesis of various disorders including inflammatory bowel disease (IBD). Summary: Under normal conditions, β-oxidation of butyrate consumes oxygen in colonocytes and maintains the anaerobic environment in the lumen. Depletion of butyrate-producing bacteria results in anaerobic glycolysis in colonocytes and increases oxygen diffusion into the lumen, leading to a luminal facultative anaerobe expansion. Dysbiosis in IBD is characterized by the reduced abundance of the phylum Firmicutes (e.g., Faecalibacterium, Roseburia, and Ruminococcus) and an increase of the phylum Proteobacteria (e.g., Enterobacteriaceae). The overall structure of the gut mycobiome differs markedly in IBD patients, particularly Crohn’s disease (CD), compared with healthy individuals. An increase in the genus Candida is a major contributory factor in the alteration of the mycobiome in Japanese CD patients, but an increase in the genus Saccharomyces is characteristic in Western patients. The gut virome, which is mainly composed of bacteriophages (phages), influences gut homeostasis and pathogenic conditions via an interaction with the gut bacterial community. Alterations in the gut virome have been suggested in patients with IBD. This may alter either the immunogenicity of bacteria, thus affecting the bacteria-host interactions, or the bacterial functions such as antibiotic resistance and toxin synthesis. Key Message: Advances in DNA sequencing technology and bioinformatics have revolutionized our understanding of the microbiome in the gut.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesCrohn DiseaseHumansDysbiosisFecesButyrates

Stichwörter der Autor:innen

ButyrateMycobiomeShort-chain fatty acidsVirome

Substanzen

Butyrates

Autor:innen und Institutionen

  • Department of Medicine, Shiga University of Medical Science, Otsu, Japan.

Zitieren

APA

Andoh, A., & Nishida, A. (2023). Alteration of the Gut Microbiome in Inflammatory Bowel Disease. Digestion, 104(1), 16-23. https://doi.org/10.1159/000525925

Vancouver

Andoh A, Nishida A. Alteration of the Gut Microbiome in Inflammatory Bowel Disease. Digestion. 2023;104(1):16-23. doi:10.1159/000525925

BibTeX
@article{Andoh2023,
  author = {Andoh, Akira and Nishida, Atsushi},
  title = {Alteration of the Gut Microbiome in Inflammatory Bowel Disease},
  journal = {Digestion},
  year = {2023},
  volume = {104},
  number = {1},
  pages = {16--23},
  doi = {10.1159/000525925}
}
Kostenlos starten →